Association between circulating hemostatic measures and dementia or cognitive impairment: Systematic review and meta-analyzes

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 8, 2011, Pages 1475-1482

  Quinn, Terry J ^a   Gallacher, J ^b   Deary, I J ^c   Lowe, G D O ^a   Fenton, C ^d   Stott, D J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MRC SOCIAL AND PUBLIC HEALTH SCIENCES UNIT   (United Kingdom)

Author keywords

Biomarkers; Coagulation; Cognition; Dementia; Hemorheology; Hemostasis

Indexed keywords

BLOOD CLOTTING FACTOR 7; D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; COGNITIVE DEFECT; DEMENTIA; ENDOTHELIAL DYSFUNCTION; HEMOSTASIS; HUMAN; LONGITUDINAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOSIS; VERBAL MEMORY;

BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DEMENTIA; HEMOSTASIS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 80051587277     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04403.x     Document Type: Article

References (46)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997; 349: 1498-504.
2. Department of Health. Living Well with Dementia: UK Government. London: Department of Health, 2009.
3. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.
4. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M. Revising the definition of Alzheimer's disease a new lexicon. Lancet Neurol 2010; 9: 1118-27.
5. Wright CF, Hall A, Matthews FE, Brayne C. Biomarkers, dementia and public health. Ann N Y Acad Sci 2009; 1180: 11-9.
6. Tsuda Y, Satoh K, Kitadai M, Takahashi T. Hemorheologic profiles of plasma, fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions. J Neurol Sci 1997; 147: 49-54.
7. Kario K, Matsuo T, Kobayashi H, Asada R, Matsuo M. Silent cerebral infarction is associated with hypercoaguability, endothial damage and high Lp(a) levels in eldelry Japanese. Arterioscler Thromb Vasc Biol 1996; 16: 734-41.
8. Neuropathology group of the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-75.
9. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol and misfolded proteins. Lancet 2004; 363: 1139-46.
10. Muniz-Terrera G, Matthews F, Dening T, Huppert FA, Brayne C. Education and trajectories of cognitive decline over 9years in very old people. Age Ageing 2009; 38: 277-82.
11. Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, Penke L, Rafnsson SB, Starr JM. Age associated cognitive decline. Br Med Bull 2009; 92: 135-52.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA group. Preferred reporting Items for systematic reviews and meta-anlayses The PRISMA statement. Ann Intern Med 2009; 151: 65-94.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Drummond R, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-anlaysis of observational studies in epidemiology a proposal for reporting. JAMA 2000; 283: 2008-12.
14. Mari D, Coppola R, Provenzano R. Hemostasis factors and aging. Exp Gerontol 2008; 43: 66-73.
15. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta-analysis Version 2. Englewood, NJ: Biostat, 2005.
16. Penin F, Voisin P, Cuny G, Stoltz JF. Etude hemorheologique et plaquettaire au cours des demences type Alzheimer. Rev de Geriatrie 1988; 13: 11-4.
17. Matsubayashi K, Matsumoto M. Haematocrit, serum lipids and cardiovascular disease. Jap J Geri 1988; 25: 576-80.
18. Kostka T, Para J, Kostka B. Correlates of plasma fibrinogen in a random sample of community dwelling elderly. Arch Gerontol Geriatr 2008; 46: 211-20.
19. Barber M, Tait RC, Scott J, Rumley A, Lowe GDO, Stott DJ. Dementia in subjects with atrial fibrillation hemostatic function and the role of anticoagulation. J Thromb Haemost 2004; 2: 1873-8.
20. Borroni B, Volpi R, Martini G, Del Bono R, Archetti S, Colciaghi F, Akkawi NM, Di Luca M, Romanelli G, Caimi L, Padovani A. Peripheral blood abnormalities in Alzheimer's disease: evidence of early endothelial function. Alzheimer Dis Assoc Disord 2002; 3: 150-5.
21. Bots ML, Breteler MM, van Kooten F, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Coagulation and fibrinolysis markers and risk of dementia The Dutch Vascular factors in Dementia Study. Haemostasis 1998; 28: 216-22.
22. Carcaillon L, Gaussem P, Ducimetiere P, Giroud M, Ritchie K, Dartigues JF, Scarabin PY. Elevated plasma fibrin Ddimer as a risk-factor for vascular dementia the Three-City cohort study. J Thromb Haemost 2009; 7: 1972-8.
23. Cerhan JR, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG, Hays MA, Crum LD, Heiss G. Correlates of cognitive function in middle aged adults. Gerontology 1998; 44: 95-105.
24. Elwood PC, Pickering J, Gallacher JEJ. Cognitive function and blood rheology results from the Caerphilly cohort of older men. Age Ageing 2001; 30: 135-9.
25. Fischer P, Zehetmayer S, Bauer K, Huber K, Jungwirth S, Tragl KH. Relation between vascular risk-factors and cognition at age 75. Acta Neurol Scand 2006; 114: 84-90.
26. Gallacher J, Bayer A, Lowe G, Fish M, Pickering J, Pedro S, Dunstan F, White J, Yarnell J, Ben-Shlomo Y. Is sticky blood bad for the brain? hemostatic and inflammatory systems and dementia in the Caerphilly prospective study. Arterioscler Thromb Vasc Biol 2010; 30: 599-604.
27. Luciano M, Marioni RE, Gow AJ, Starr JM, Deary IJ. Reverse causation in the association between c-reactive protein and fibrinogen levels and cognitive abilities in an ageing sample. Psychosom Med 2009; 71: 404-9.
28. Magniafo RA, Sarnatoro F, Mangiafico M, Fiore CE. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to c-reactive protein and D-dimer. Age Ageing 2006; 35: 60-5.
29. Mari D, Parnetti L, Coppola R, Bottasso B, Reboldi GP, Senin U, Mannucci PM. Hemostasis abnormalities in patients with vascular dementia and alzheimer's disease. Thromb Haemost 1996; 75: 216-8.
30. Marioni RE, Stewart MC, Murray GD, Deary IJ, Fowkes FGR, Lowe GDO, Rumley A, Price JF. Peripheral levels of fibrinogen, c-reactive protein and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med 2009; 71: 901-6.
31. Marioni RE, Deary IJ, Strachan MW, Lowe GDO, Rumley A, Murray GD, Price JF. Blood rheology and cognition in the Edinburgh type 2 diabetes study. Age Ageing 2010; 40: 1-6.
32. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GDO, Fowkes GR. Cognitive decline and markers of inflammation and hemostasis the Edinburgh Artery Study. J Am Geriatr Soc 2007; 55: 700-7.
33. Rafnsson S, Deary IJ, Whiteman MC, Rumley A, Lowe GDO, Fowkes FGR. Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. Age Ageing 2010; 39: 217-22.
34. Ravaglia G, Forti P, Maioli F, Arnone G, Pantieri G, Cocci C, Nativio V, Muscari A, Pedone V, Mariani E. The clock-drawing test in elderly Italian community dwellers associations with sociodemographic status and risk factors for vascular cognitive impairment. Dement Geriatr Cogn Disord 2003; 16: 287-95.
35. Stott DJ, Spilg E, Campbell AM, Rumley A, Mansoor MA, Lowe GDO. Haemostasis in ischaemic stroke and vascular dementia. Blood Coagul Fibrinolysis 2001; 12: 651-7.
36. Stott DJ, Robertson MJ, Rumley A, Welsh P, Sattar N, Packard CJ, Shepherd J, Trompet S, Westendorp RG, de Craen AJ, Jukema JW, Buckley B, Ford I, Lowe GD. Activation of haemostasis and decline in cognitive function in older people. Arterioscler Thromb Vasc Biol 2010; 30: 605-11.
37. van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MB. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 2005; 36: 2637-41.
38. Wilson CJ, Cohen JJ, Pieper CF. Cross-linked fibrin degradation products (DDimer), plasma cytokines, and cognitive decline in community dwelling elderly persons. J Am Geriatr Soc 2003; 51: 1374-81.
39. Austin H, Hill HA, Flanders DW, Greenberg RS. Limitations in the application of case-control methodology. Epidemiol Rev 1994; 16: 65-76.
40. Wannamethee GS, Lowe GDO, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785-90.
41. Mhatre M, Nguyen A, Kashani S, Pham T, Adesina A, Grammas P. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging 2004; 25: 783-93.
42. Walzl M, Lechner H, Walzl B, Schied G. Improved neurological recivery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. Stroke 1993; 24: 1447-51.
43. Rands G, Orrell M, Spector AE. Aspirin for vascular dementia. Cochrane Database Syst Rev 2000; 3: CD001296.
44. Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, van Gool WA, Nederkoorn PJ. Aspirin in Alzheimer's disease increased risk of intracerebral hemorrhage cause for concern. Stroke 2010; 41: 2690-2.
45. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 2009; 6: e100018.
46. Marioni RE, Deary IJ, Murray GD, Lowe GDO, Strachan MWJ, Luciano M, Houlihan L, Gow A, Harris S, Rumley A, Stewart M, Fowkes F, Price J. Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts. Behav Genet. 2011.